John Peter Gutfreund - 30 Jun 2023 Form 4 Insider Report for Oncocyte Corp (OCX)

Signature
/s/ John Peter Gutfreund
Issuer symbol
OCX
Transactions as of
30 Jun 2023
Transactions value $
$0
Form type
4
Filing time
03 Jul 2023, 18:00:08 UTC
Previous filing
05 Apr 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Other $0 -3,085,047 -100% $0* 0 30 Jun 2023 See Footnotes F1, F2, F3
holding OCX Common Stock, no par value 3,079,372 30 Jun 2023 See Footnotes F3, F4, F5
holding OCX Common Stock, no par value 25,000 30 Jun 2023 See Footnotes F3, F6
holding OCX Common Stock, no par value 715,000 30 Jun 2023 Direct F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCX Warrants to Purchase Common Stock Other $0 -3,564,728 -100% $0* 0 30 Jun 2023 Common Stock 3,001,876 $1.53 See Footnotes F3, F8, F9, F10
holding OCX Warrants to Purchase Common Stock 992,495 30 Jun 2023 Common Stock 835,785 $1.53 See Footnotes F3, F9, F11, F12
holding OCX Warrants to Purchase Common Stock 45,000 30 Jun 2023 Common Stock 45,000 $0.97 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

John Peter Gutfreund is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock of Oncocyte Corporation (the "Issuer"), no par value (the "Common Stock"), that were distributed by Halle Special Situations Fund LLC (the "Halle Fund") on a pro rata basis to its members (the "Halle Common Stock Distribution").
F2 Represents shares of Common Stock directly beneficially owned by the Halle Fund. John Peter Gutfreund (the "Reporting Person") is the investment manager and a control person of Halle Capital Partners GP LLC, the managing member of the Halle Fund. In such capacity, the Reporting Person may be deemed to beneficially own any securities directly owned by the Halle Fund.
F3 The Reporting Person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise, the beneficial owner of any securities covered by this statement. The Reporting Person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of the Reporting Person in such securities.
F4 Includes 2,004,372 shares of Common Stock received by Newtown Road 130 Holdings LLC ("Newtown") from the Halle Fund as a result of the Halle Common Stock Distribution. The acquisition of the shares of Common Stock by Newtown in the Halle Common Stock Distribution constituted a change in the form of beneficial ownership without a change in pecuniary interest that is exempt from Section 16 of the Exchange Act pursuant to Rule 16a-13 thereunder. Rule 16a-9(a) under the Exchange Act may also exempt the acquisition of the shares of Common Stock by Newtown in the Halle Common Stock Distribution from Section 16 of the Exchange Act.
F5 Represents shares of Common Stock directly beneficially owned by Newtown. The Reporting Person is the managing member and a control person of Newtown. In such capacity, the Reporting Person may be deemed to beneficially own any securities directly owned by Newtown.
F6 Represents shares of Common Stock held by or for the benefit of the minor children of the Reporting Person, and the Reporting Person has voting and dispositive control over such securities. In such capacity, the Reporting Person may be deemed to beneficially own any securities held by or for the benefit of the minor children of the Reporting Person.
F7 Includes 10,000 restricted stock units, which will vest on August 15, 2023.
F8 Represents warrants to purchase shares of Common Stock (the "Warrants") that were distributed by the Halle Fund on a pro rata basis to its members (the "Halle Warrant Distribution").
F9 The Warrants are currently exercisable, subject to a beneficial ownership limitation of 4.99%.
F10 Represents Warrants directly beneficially owned by the Halle Fund. The Reporting Person is the investment manager and a control person of Halle Capital Partners GP LLC, the managing member of the Halle Fund. In such capacity, the Reporting Person may be deemed to beneficially own any securities directly owned by the Halle Fund.
F11 Represents Warrants received by Newtown from the Halle Fund as a result of the Halle Warrant Distribution. The acquisition of the Warrants by Newtown in the Halle Warrant Distribution constituted a change in the form of beneficial ownership without a change in pecuniary interest that is exempt from Section 16 of the Exchange Act pursuant to Rule 16a-13 thereunder. Rule 16a-9(a) under the Exchange Act may also exempt the acquisition of the Warrants by Newtown in the Halle Warrant Distribution from Section 16 of the Exchange Act.
F12 Represents Warrants directly beneficially owned by Newtown. The Reporting Person is the managing member and a control person of Newtown. In such capacity, the Reporting Person may be deemed to beneficially own any securities directly owned by Newtown.
F13 The options to purchase shares of Common Stock will vest on August 15, 2023.